Trevi Therapeutics (TRVI) Shares Outstanding (2018 - 2026)
Trevi Therapeutics (TRVI) Shares Outstanding (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 6,012.74 Bn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | 47.82 Bn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 118.76 Bn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 1.44 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.10 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 400.00 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 62.06 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 198.10 Mn |
| 10 | Trevi Therapeutics | 2.54 Bn | 2.54 Bn | - | 145.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 145.59 Mn |
| Dec 31, 2025 | 134.75 Mn |
| Sep 30, 2025 | 145.10 Mn |
| Jun 30, 2025 | 130.35 Mn |
| Mar 31, 2025 | 117.61 Mn |
| Dec 31, 2024 | 101.97 Mn |
| Sep 30, 2024 | 101.28 Mn |
| Jun 30, 2024 | 101.04 Mn |
| Mar 31, 2024 | 99.52 Mn |
| Dec 31, 2023 | 99.03 Mn |
| Sep 30, 2023 | 99.33 Mn |
| Jun 30, 2023 | 98.70 Mn |
| Mar 31, 2023 | 98.61 Mn |
| Dec 31, 2022 | 64.54 Mn |
| Sep 30, 2022 | 68.90 Mn |
| Jun 30, 2022 | 59.54 Mn |
| Mar 31, 2022 | 30.81 Mn |
| Dec 31, 2021 | 22.84 Mn |
| Sep 30, 2021 | 21.61 Mn |
| Jun 30, 2021 | 20.12 Mn |